
Landmark Bio is a cell and gene therapy manufacturing company dedicated to developing innovative technologies and services to advance therapeutic targets from research to clinical applications. The company offers solutions for academic researchers, physician scientists, and biopharma leaders to streamline development processes, accelerate timelines, and overcome obstacles in the drug discovery pipeline.
Landmark Bio is seeking a highly motivated Director to lead the development of next-generation biomanufacturing platforms focused on continuous and integrated bioprocessing. This role involves leading internal innovation initiatives, collaborating with clients, and ensuring seamless integration of new technologies into GMP workflows, particularly with extracellular vesicles and viral vectors. Landmark Bio is an acquisition by Artis BioSolutions and has become a distinct entity following that acquisition.
Landmark Bio is a cell and gene therapy manufacturing company dedicated to developing innovative technologies and services to advance therapeutic targets from research to clinical applications. The company offers solutions for academic researchers, physician scientists, and biopharma leaders to streamline development processes, accelerate timelines, and overcome obstacles in the drug discovery pipeline.
Kernal Biologics